These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1343144)

  • 41. [The effect of the parameters of the therapeutic protocol on the efficacy of the adjuvant chemotherapy of breast cancer].
    Nekhme A
    Lik Sprava; 1999 Jun; (4):137-42. PubMed ID: 10476666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast carcinoma in young patients.
    Guinee VF; Moller T
    Lancet; 2000 Sep; 356(9235):1113. PubMed ID: 11009170
    [No Abstract]   [Full Text] [Related]  

  • 43. [Adjuvant chemotherapy and mastectomy].
    Veselý F; Pelikán A
    Rozhl Chir; 1988 Jul; 67(7):455-60. PubMed ID: 3175776
    [No Abstract]   [Full Text] [Related]  

  • 44. [The influence of post-operative radiotherapy on adjuvant chemotherapy: an analysis of stage III breast cancer patients].
    Tang SG; Lin FJ; Chen MS; Leung W; Leung WM
    Changgeng Yi Xue Za Zhi; 1987 Mar; 10(1):51-7. PubMed ID: 3455274
    [No Abstract]   [Full Text] [Related]  

  • 45. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast.
    Schwartz GF; Cantor RI; Biermann WA
    Arch Surg; 1987 Dec; 122(12):1430-4. PubMed ID: 3689121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials on adjuvant chemotherapy for breast cancer.
    Semiglazov VF; Bavli JL; Moiseyenko VM; Rzhankov SV; Migmanova NS; Popova RT; Seleznyov IK; Kremen BV; Kostetskaya TV; Barash NJ
    Cancer; 1986 May; 57(10):1957-60. PubMed ID: 3082506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant CMF chemotherapy in operable breast cancer: ten years later.
    Bonadonna G; Rossi A; Valagussa P
    World J Surg; 1985 Oct; 9(5):707-13. PubMed ID: 3840626
    [No Abstract]   [Full Text] [Related]  

  • 48. [Chemotherapy using the CMF regimen (cyclophosphamide, methotrexate, and 5-fluorouracil) and the VAC protocol (vincristine, adriamycin and cyclophosphamide) in patients with advanced breast cancer].
    Glińska H; Zulichowska J; Radziszewska J; Sukiennik-Siuda M; Trabka E
    Nowotwory; 1987; 37(3):251-61. PubMed ID: 3438177
    [No Abstract]   [Full Text] [Related]  

  • 49. Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial.
    Derman DP; Browde S; Kessel IL; De Moor NG; Lange M; Dansey R; Seymour L; Bezwoda WR
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):257-61. PubMed ID: 2666363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of chemotherapy on the morphology of human breast carcinoma.
    Close PM; Tiltman AJ; Hacking EA
    S Afr Med J; 1987 Jul; 72(2):103-6. PubMed ID: 3039671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant CMF chemotherapy in operable breast cancer: ten years later.
    Bonadonna G; Rossi A; Valagussa P
    Lancet; 1985 Apr; 1(8435):976-7. PubMed ID: 2859425
    [No Abstract]   [Full Text] [Related]  

  • 52. High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question.
    Clin Breast Cancer; 2000 Oct; 1(3):191-2. PubMed ID: 11899643
    [No Abstract]   [Full Text] [Related]  

  • 53. [Regional lymphotropic chemotherapy in breast cancer--a new approach in the therapeutic procedure for the parasternal lymph nodes].
    Baĭchev G; Deliĭski T; Polovska S; Boĭkov M
    Khirurgiia (Sofiia); 1998; 51(1):14-7. PubMed ID: 9854934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservative surgery in breast cancer.
    Veronesi U; Costa A
    Ann N Y Acad Sci; 1993 Nov; 698():212-8. PubMed ID: 8279760
    [No Abstract]   [Full Text] [Related]  

  • 55. Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy.
    Geller NL; Hakes TB; Petroni GR; Currie V; Kaufman R
    Cancer; 1990 Oct; 66(8):1678-84. PubMed ID: 2208022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoadjuvant (preoperative) chemotherapy for breast cancer.
    Ragaz J; Baird R; Rebbeck P; Goldie J; Coldman A; Spinelli J
    Cancer; 1985 Aug; 56(4):719-24. PubMed ID: 4016668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
    Sulkes A; Brufman G; Rizel S; Weshler Z; Biran S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):17-21. PubMed ID: 6687724
    [No Abstract]   [Full Text] [Related]  

  • 58. Preoperative adjuvant chemotherapy (neoadjuvant) for carcinoma of the breast: rationale and safety report.
    Ragaz J; Baird R; Rebbeck P; Goldie A; Coldman A; Spinelli J
    Recent Results Cancer Res; 1985; 98():99-105. PubMed ID: 3839932
    [No Abstract]   [Full Text] [Related]  

  • 59. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.
    Blumenschein GR; Buzdar AU; Hortobagyi GN
    Recent Results Cancer Res; 1984; 96():129-32. PubMed ID: 6528087
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of post-operative radiotherapy in the treatment of operable breast cancer.
    Beadle GF; Harris JR
    Breast Cancer Res Treat; 1984; 4(3):159-68. PubMed ID: 6386074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.